3 recruiting, 1 active not recruiting, 1 unknown. 2 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Bicalutamide 50 mg: new trials by email Literature Review of Bicalutamide 50 mg trials Research Report on Bicalutamide 50 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bicalutamide Therapy in Young Women With NAFLD and PCOS Bicalutamide 50 mg, Placebo - NAFLD, PCOS | Phase 1 | Recruiting | University of California, San Francisco | 50 | 2024-02-14 | 2026-05-29 |
| The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2 Bicalutamide 50 mg - Polycystic Ovary Syndrome, Androgen Excess | Not applicable | Unknown | Royal College of Surgeons, Ireland | 16 | 2023-01-01 | 2022-12-12 |
| Phase II Dutasteride in Combination With CAB vs CAB in SDC Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg - Salivary Duct Carcinoma | Phase 2 | Recruiting | Radboud University Medical Center | 26 | 2022-09-27 | 2025-06-04 |
| SRT Versus SRT+ADT in Prostate Cancer Triptorelin Embonate, Bicalutamide 50 mg - Prostate Cancer | Phase 3 | Recruiting | Marco Lorenzo Bonu | 310 | 2021-09-30 | 2023-04-18 |
| Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone Radiotherapy 70 Gy, Radiotherapy 76 Gy, Androgen blockade - Prostate Cancer | Phase 3 | Active not recruiting | Abdenour Nabid | 600 | 2000-12-01 | 2025-01-27 |
Prostatic Neoplasms (2) · Hyperandrogenism (1) · Metabolic Diseases (1) · Non-alcoholic Fatty Liver Disease (1) · Polycystic Ovary Syndrome (1)
Abdenour Nabid (1) · Marco Lorenzo Bonu (1) · Radboud University Medical Center (1) · Royal College of Surgeons, Ireland (1) · University of California, San Francisco (1)
Canada (1) · Ireland (1) · Italy (1) · Netherlands (1) · United States (1)
Abdenour Nabid, MD (1) · Luca Triggiani, MD PHD (1) · Monika A Sarkar, MD, MAS (1)
R01DK134633 (1)